RAYSEARCH LABORATORIES AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 117 SEK | +2.45% |
|
+2.63% | +29.57% |
Presenter SpeechEva Nelson (Executives)Hello, and welcome to the presentation of RaySearch Yea...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
RaySearch Laboratories publ AB is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. As of December 31, 2011, 15 of the Companyâs products were launched, including the software platform ORBIT (optimization of radiation therapy beams by iterative technique), which is available in its main products, and is a non-clinical system which functions as a research and development environment. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Companyâs commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Calendar
2024-05-16
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
117
SEK
Average target price
135
SEK
Spread / Average Target
+15.38%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +29.57% | 366M | |
| +4.36% | 32.47B | |
| +14.14% | 7.45B | |
| +22.93% | 3.89B | |
| -16.29% | 3.15B | |
| -25.96% | 1.28B | |
| -36.14% | 1.09B | |
| -35.42% | 902M | |
| -0.13% | 893M | |
| -24.12% | 857M |
- Stock Market
- Equities
- RAY B Stock
- News RaySearch Laboratories AB
- Transcript : RaySearch Laboratories AB, 2023 Earnings Call, Feb 23, 2024
